“The Iran-made MS drug which was produced four years ago has now been approved in the international scientific circles and entered the export arena,” Director-General of the Iranian Health Ministry for Medication Mohammad Reza Shanehsaz told FNA, adding that the drug is currently exported to Syria and Armenia.
Shanehsaz also announced that other countries have also demanded to import Iran-made MS drugs as well as other Iranian medications.
Due to the high quality of Iran-made medicines and their cost-effectiveness, the country will be turned into one of the most important exporters of medicines in the region, he added.
Iran introduced two home-made MS drugs, namely Resigene (interferon beta 1a) and Cinnovex, in the last few years.
Also, a well-known Iranian company started mass production of a third Iran-made MS medication under the generic name of ‘Ziferon’ on Saturday.
Interferon beta 1, generically known as Ziferon, is mainly injected subcutaneously and has antiviral and immunomodulating properties. The drug is mainly used in the management of multiple sclerosis, although its mode of action is unclear.
The Center for Pharmaceutical Products has already produced five biotechnological drugs, making Ziferon the sixth medication produced by the company.
Fars News